Philip Herman
Corporate Officer/Principal at REPARE THERAPEUTICS INC.
Net worth: 18 482 $ as of 2024-03-30
Profile
Philip Karl Herman is currently the Executive VP-Commercial & New Product Development at Repare Therapeutics, Inc. He previously worked as the Marketing Director at Vanda Pharmaceuticals, Inc. and as the Vice President, Head-Commercial & Marketing at Dyax Corp.
From 2018 to 2021, he served as the Chief Commercial Officer & Senior Vice President at Y-mAbs Therapeutics, Inc. Mr. Herman holds an MBA degree from Kellogg School of Management and an undergraduate degree from Baldwin Wallace University School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPARE THERAPEUTICS INC.
0.01% | 2024-03-31 | 3,924 ( 0.01% ) | 18 482 $ | 2024-03-30 |
Philip Herman active positions
| Companies | Position | Start |
|---|---|---|
| REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 2022-01-04 |
Former positions of Philip Herman
| Companies | Position | End |
|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-12-30 |
| VANDA PHARMACEUTICALS INC. | Sales & Marketing | - |
| DYAX CORP. | Sales & Marketing | - |
Training of Philip Herman
| Kellogg School of Management | Masters Business Admin |
| Baldwin Wallace University School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VANDA PHARMACEUTICALS INC. | Health Technology |
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Stock Market
- Insiders
- Philip Herman